More Globe Newswire

View Older Stories View Newer Stories

Mar 11, 2024 07:29AM Bengala Technologies and Mempool Ventures: A Partnership That Will Level Up Your Business

Mar 11, 2024 07:28AM At the Primo Cup in Monaco innovation is at the centre of the regatta

Mar 11, 2024 07:22AM Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares

Mar 11, 2024 07:19AM Dimensional Fund Advisors Ltd. : Form 8.3 - Urban Logistics REIT plc - Ordinary Shares

Mar 11, 2024 07:15AM Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update

Mar 11, 2024 07:15AM Flow Capital Announces a $2.15 Million Loan to a Fintech Company

Mar 11, 2024 07:13AM Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares

Mar 11, 2024 07:12AM Park Street A/S – Share buyback program 2024

Mar 11, 2024 07:10AM Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRENT COMMUNICATIONS PLC - Ordinary Shares

Mar 11, 2024 07:09AM Dimensional Fund Advisors Ltd. : Form 8.3 - Redrow plc - Ordinary Shares

Mar 11, 2024 07:07AM Dimensional Fund Advisors Ltd. : Form 8.3 - MONDI PLC - Ordinary Shares

Mar 11, 2024 07:06AM Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares

Mar 11, 2024 07:05AM Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)

Mar 11, 2024 07:05AM Manhattan Bridge Capital, Inc. Reports Results for 2023

Mar 11, 2024 07:04AM Dimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares

Mar 11, 2024 07:05AM Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities

Mar 11, 2024 07:02AM Dimensional Fund Advisors Ltd. : Form 8.3 - CUSTODIAN PROPERTY INCOME RE - Ordinary Shares

Mar 11, 2024 07:00AM Microbix Unveils Test Controls for Head and Neck Cancer

Mar 11, 2024 07:00AM Corporate Update: Meni Morim to Step Down as CEO

Mar 11, 2024 07:00AM Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares

Mar 11, 2024 07:00AM Clarus Files Lawsuit Against Caption Management LLC, Caption Partners II LP, Caption GP, LLC, William Cooper and Jason Strasser for Recovery of Short-Swing Profits

Mar 11, 2024 07:00AM Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol

Mar 11, 2024 07:00AM Abaxx Prepares Exchange Opening Sequence and Final Notices

Mar 11, 2024 07:00AM Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division

Mar 11, 2024 07:00AM Cielo Announces Closing of First Tranche of Private Placement of Convertible Debenture Units

Mar 11, 2024 07:00AM Emerita Intersects 68.9 Meters Grading 0.7% Copper; 0.3% Lead; 0.5% Zinc, 0.91 g/t Gold and 36.2 g/t Silver, Including 9.4 Meters Grading 0.9% Copper; 0.3% Lead; 1.4% Zinc, 1.59 g/t Gold and 37.8 g/t

Mar 11, 2024 07:00AM Pulsar Helium Special Virtual Conference Today Register Now

Mar 11, 2024 07:00AM Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases

Mar 11, 2024 07:00AM Lantronix to Participate in 36th Annual Roth Conference Held March 17–19, 2024

Mar 11, 2024 07:00AM Monte Rosa Therapeutics Announces Initiation of IND Enabling Studies for MRT-8102, A First-in-Class NEK7 Directed Molecular Glue Degrader and NLRP3/IL-1β Pathway Inhibitor

Mar 11, 2024 07:00AM Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event

Mar 11, 2024 07:00AM Plymouth Industrial REIT Development Projects in Jacksonville Earn Green Globes® Certification for Core & Shell Construction

Mar 11, 2024 07:00AM ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

Mar 11, 2024 07:00AM FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

Mar 11, 2024 07:00AM Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA

Mar 11, 2024 07:00AM Arvig to Invest Grant Funding in $5 Million Fiber Expansion for 3 Minnesota Counties

Mar 11, 2024 07:00AM mdf commerce enters definitive agreement to be acquired by KKR

Mar 11, 2024 07:00AM ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients

Mar 11, 2024 07:00AM Tower Semiconductor to Present at 2024 SEMICON China Addressing Advanced CMOS Process Technology for Micro Displays

Mar 11, 2024 07:00AM Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Mar 11, 2024 07:00AM Smart Share Global Limited Declares a Special Cash Dividend

Mar 11, 2024 07:00AM Tecnoglass to Present at the Sidoti Virtual Small Cap Conference

Mar 11, 2024 07:00AM Autolus Therapeutics announces publication in Blood Cancer Journal

Mar 11, 2024 07:00AM Akoustis to Attend the 36th Annual Roth Conference on March 17-19, 2024

Mar 11, 2024 07:00AM Amplify Energy Update on Southern California Oil Sheen

Mar 11, 2024 07:00AM ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio

Mar 11, 2024 07:00AM Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial

Mar 11, 2024 07:00AM Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor

Mar 11, 2024 07:00AM ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

Mar 11, 2024 07:00AM Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub

View Newer Stories View Older Stories